Mechanistically, chemotherapy promotes macrophage secretion of interleukin (IL)−18, which upregulates LAT2 expression in tumor cells and consequently enhances glutamine and leucine uptake- and mTOR activity-dependent CD47 expression for tumor immune envision. This evidence concerns the gene MTOR and neoplasm.